Providers

AbstractBackgroundGrade 2 or 3 uptake on 99mTc-pyrophosphate scintigraphy is a cornerstone for diagnosing transthyretin amyloidosis. However, light-chain…

Why not join us for this online support group for those affected by Cardiac Amyloidosis (ATTR-CM)?People with Cardiac Amyloidosis (ATTR-CM), as well as supporters,…

Highlights•Transthyretin amyloidosis cardiomyopathy progression can be slowed with treatment.•Musculoskeletal conditions commonly occur in the years preceding…

Former Penn State All-American defensive lineman Matt Millen's journey back to broadcast booth was chronicled in an episode of "The B1G Story" Tuesday night. Two…

Daniel John Matheson, 69, of Edmonton, Alberta, passed away peacefully on Monday, July 13, 2026, surrounded by the love of those whose lives he touched so deeply.…

BridgeBio is a biotechnology company designing transformative medicines for patients with genetic diseases and cancers with clear genetic drivers.

Alnylam Pharmaceuticals, Inc. is an American biopharmaceutical company focused on the discovery, development and commercialization of RNA interference (RNAi)…

Dr. Bianchi is a physician-scientist and Associate Director of the Amyloidosis Program at Brigham and Women's Hospital/Dana Farber Cancer Institute and Assistant…

Fabio is a patient with hereditary amyloidosis in Brazil (ATTRv). Here he explains his struggle to get a diagnosis and treatment in Brazil.

Paula Schmitt is the executive director and patient registry manager of the Amyloidosis Support Groups (ASG)external link, opens in a new tab. As the executive…